SCHEMBL17599349

SCHEMBL17599349

Cc1ccc2c(NS(=O)(=O)c3c(C)c(C)cc(C)c3C)ccc(-c3cc(C(=O)O)ccc3F)c2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ HSD17B10 Q99714 2/20 0.43
▸ CRHBP P24387 1/20 0.43
▸ CRHR2 Q13324 1/20 0.43
▸ KEAP1 Q14145 4/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ NFE2L2 Q16236 1/20 0.39
▸ FABP4 P15090 1/20 0.36
▸ PTK2B Q14289 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ ACLY P53396 3/20 0.35
▸ LMNA P02545 3/20 0.34
▸ GAA P10253 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599370 0.84 ALDH1A1 (0.53) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL17599373 0.84 KMT2A (0.46) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL17599396 0.80 KEAP1 (0.38) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL17599375 0.71 ACLY (0.49) MEN1KMT2AALDH1A1KDM4EKEAP1
SCHEMBL17599385 0.70 TSHR (0.47) KMT2ASMN1; SMN2FABP4PTK2BL3MBTL1
SCHEMBL17599305 0.70 ACLY (0.55) SMN1; SMN2FABP4PTK2BL3MBTL1ACLY
SCHEMBL17599320 0.70 SMN1; SMN2 (0.54) MEN1KMT2AKDM4EHPGDSMN1; SMN2
SCHEMBL17599329 0.70 KMT2A (0.55) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL17599358 0.69 ALDH1A1 (0.58) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL17599341 0.69 FABP4 (0.43) KMT2AALDH1A1HSD17B10KEAP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP claimed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998294-A1 Naphthyl sulfonamide phenyl derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback